{"id":"c1875","number":1655,"headline":{"en":"Anticancer peptide prediction","da":"Anticancer peptidprediktion"},"content":{"en":"Anticancer peptide prediction: Scientists have been exploring the use of algorithms to identify and predict anticancer peptides. Various deep learning architectures, such as DeepACP and ACP-MHCNN, have been developed to achieve the best performance in this task. Other algorithms, like ENNAACT and iACP-DRLF, use neural networks and deep representation learning features to accurately classify and discriminate anticancer peptides. These advancements in machine learning tools, including convolutional neural networks and Siamese networks, offer promising potential for the development of effective anticancer therapies.","da":"Anticancer peptidprediktion: Forskere har undersøgt brugen af algoritmer til at identificere og forudsige anticancerpeptider. Forskellige dybdelæringsarkitekturer, såsom DeepACP og ACP-MHCNN, er blevet udviklet for at opnå den bedste ydeevne i denne opgave. Andre algoritmer, som ENNAACT og iACP-DRLF, bruger neurale netværk og dybdegående læringsrepræsentationer til nøjagtigt at klassificere og skelne anticancerpeptider. Disse fremskridt inden for maskinlæringsværktøjer, herunder konvolutionsneuronetværk og siamesiske netværk, tilbyder lovende potentiale for udviklingen af effektive anticancerbehandlinger."},"bots":{"critic":{"en":null,"da":null},"potential":{"en":null,"da":null}}}